PropThink: Momentum To Continue On SNSS; Investor Day Tomorrow, Analysts Raising Target

[ACN Newswire] – By David MoskowitzSunesis Pharmaceuticals (NASDAQ:SNSS) has had a great year thus far, up 350% since January, and importantly, the smart money continues to flock to the name. The key driver is the company’s … more

View todays social media effects on SNSS

View the latest stocks trending across Twitter. Click to view dashboard